Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis (Q28280822)

2

0 references

Mona L Gauthier

3

0 references

Hal K Berman

4

0 references

Fred Waldman

5

0 references

James Bennington

6

0 references

Henry Sanchez

7

0 references

Cynthia Jimenez

8

0 references

Kim Stewart

9

0 references

Karen Chew

10

0 references

Britt-Marie Ljung

11

0 references

Thea D Tlsty

Journal of the National Cancer Institute

12

0 references

language of work or name

English

0 references

publication date

5 May 2010

0 references

published in

0 references

volume

102

0 references

page(s)

627-37

0 references

issue

9

0 references

cites work

Genes that mediate breast cancer metastasis to lung

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Detection of ductal carcinoma in situ in women undergoing screening mammography

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Consensus Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, April 22-25, 1999.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Epidemiology of contralateral breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Identification of a basal-like subtype of breast ductal carcinoma in situ

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Trends in breast cancer by race and ethnicity: update 2006.

2 June 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ101

Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ101

Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ101

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ101

Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ101

Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ101

High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ101

Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ101

Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ101

Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ101

Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ101

Predicting axillary nodal positivity in 2282 patients with breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ101

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864293

Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy

27 November 2018

1 reference

12 December 2020

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

1 reference

12 December 2020

Pathologists' agreement with experts and reproducibility of breast ductal carcinoma-in-situ classification schemes

1 reference

12 December 2020

Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status

1 reference

12 December 2020

Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer

1 reference

12 December 2020

The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis

1 reference

12 December 2020

Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trial

1 reference

12 December 2020

Ductal carcinoma in situ of the breast: 11 reasons to consider treatment with excision alone

1 reference

12 December 2020

Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJQ101

1 reference

1764917

1764917

1 reference

1 reference

1 reference